T细胞受体
细胞生物学
封锁
受体
T细胞
信号转导
化学
原癌基因酪氨酸蛋白激酶Src
阻塞(统计)
抗体
免疫疗法
阻断抗体
酪氨酸激酶
共刺激
细胞
生物
癌症免疫疗法
抑制器
酪氨酸
受体酪氨酸激酶
癌症研究
信号转导衔接蛋白
免疫检查点
细胞信号
负调节器
抗原
过程(计算)
共受体
程序性细胞死亡
作者
Edward Jenkins,Martin Fellermeyer,Daniel F. Heraghty,Sumana Sharma,Tanmay Mitra,Mateusz Kotowski,J Clarke,Yuan Lui,Sam Daly,Zach Marin,Debasis Banik,Markus Körbel,Emily Zhi Qing Ng,Thomas Lister,Ana Mafalda Santos,Steven F. Lee,Michael L. Dustin,Simon J. Davis,David Klenerman
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2026-05-15
卷期号:11 (119): eadz4983-eadz4983
被引量:1
标识
DOI:10.1126/sciimmunol.adz4983
摘要
Lymphocyte activation relies on the integration of signals from multiple receptors at cell-cell contacts, but the spatiotemporal regulation of this process is unclear. Here, we show that programmed cell death protein 1 (PD-1) and T cell receptor (TCR) signals are integrated at nanoscale microvillar close contacts formed during T cell interactions with their targets. PD-1 signaling begins as these contacts form and selectively limits the duration, but not the amplitude, of TCR signaling. PD-1 suppresses TCR activity directly, by locally recruiting Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP2), and indirectly, by reducing cell-spreading, close-contact formation, and TCR engagement. A PD-1 blocking antibody induced inhibitory signaling when Fc receptor engagement trapped PD-1 at close contacts. Engineering the antibody to prevent PD-1 trapping eliminated these agonistic effects and improved blockade efficacy. These findings identify microvillar contacts as crucial hubs of initial signal integration and provide a framework for optimizing checkpoint immunotherapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI